{"id":11358,"date":"2024-03-27T15:56:55","date_gmt":"2024-03-27T14:56:55","guid":{"rendered":"https:\/\/kloepfel.sempre-diritto.de\/2024\/03\/27\/novo-nordisk-kauft-deutsche-biotechfirma\/"},"modified":"2025-08-27T11:28:44","modified_gmt":"2025-08-27T09:28:44","slug":"novo-nordisk-buys-german-biotech-firm","status":"publish","type":"post","link":"https:\/\/kloepfel-consulting.com\/en\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/","title":{"rendered":"Novo Nordisk acquires German biotech company"},"content":{"rendered":"<h2>Over one billion euros for the acquisition of Cardior<\/h2>\n<p>Novo Nordisk acquires the Hanover-based biotechnology company Cardior Pharmaceuticals. According to Novo Nordisk, this strengthens <strong>Product pipeline<\/strong> in the area of cardiovascular diseases.<\/p>\n<p>As the two companies announced on Monday, an agreement to this effect has been reached. According to the agreement, the purchase price will be up to 1.025 billion euros. According to the press release, this sum includes an upfront payment and further payments if certain targets are met.<\/p>\n<p>According to Novo Nordisk, Cardior is a company that is a leader in the <em>Research and development <\/em>of therapies with RNA-based drugs for the treatment of heart disease. As part of the transaction, Novo Nordisk will also acquire Cardior's lead product CDR1321.<\/p>\n<p>According to the press release, this drug is currently undergoing phase 2 clinical trials and may one day be used to treat heart failure.<\/p>\n<p>As Novo Nordisk explains in its press release, the company wants to build up a therapy portfolio for cardiovascular diseases through its own and acquired innovations. According to the Danish pharmaceutical manufacturer, these diseases are the most common cause of death worldwide.<\/p>\n<p>The transaction is still subject to regulatory approvals. The two companies expect the acquisition to be completed in the second quarter of 2024.<\/p>","protected":false},"excerpt":{"rendered":"<p>\u00dcber eine Milliarde Euro f\u00fcr die \u00dcbernahme von Cardior Novo Nordisk \u00fcbernimmt das in Hannover ans\u00e4ssige Biotechnologieunternehmen Cardior Pharmaceuticals. Damit st\u00e4rkt Novo Nordisk nach eigener Aussage seine Produktpipeline im Bereich der Herz-Kreislauf-Erkrankungen. Wie die beiden Unternehmen am Montag bekanntgaben, wurde eine entsprechende Vereinbarung getroffen. Demnach wird der Kaufpreis bis zu 1,025 Milliarden Euro betragen. In [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":11359,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[88],"tags":[],"referenzkategorie":[],"class_list":["post-11358","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-supply-chain-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Novo Nordisk kauft deutsche Biotechfirma<\/title>\n<meta name=\"description\" content=\"Novo Nordisk \u00fcbernimmt das in Hannover ans\u00e4ssige Biotechnologieunternehmen Cardior Pharmaceuticals. Damit st\u00e4rkt Novo Nordisk nach eigener\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kloepfel-consulting.com\/en\/supply-chain-news\/novo-nordisk-buys-german-biotech-firm-11358\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novo Nordisk kauft deutsche Biotechfirma\" \/>\n<meta property=\"og:description\" content=\"Novo Nordisk \u00fcbernimmt das in Hannover ans\u00e4ssige Biotechnologieunternehmen Cardior Pharmaceuticals. Damit st\u00e4rkt Novo Nordisk nach eigener Aussage seine Produktpipeline im Bereich der Herz-Kreislauf-Erkrankungen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kloepfel-consulting.com\/en\/supply-chain-news\/novo-nordisk-buys-german-biotech-firm-11358\/\" \/>\n<meta property=\"og:site_name\" content=\"KLOEPFEL by EPSA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/KloepfelGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-27T14:56:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-27T09:28:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/07\/kloepfelgroup.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"2200\" \/>\n\t<meta property=\"og:image:height\" content=\"1608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"semprediritto\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Novo Nordisk kauft Cardior Pharmaceuticals f\u00fcr 1 Milliarde Euro\" \/>\n<meta name=\"twitter:description\" content=\"Informieren Sie sich \u00fcber die \u00dcbernahme von Cardior durch Novo Nordisk.\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"semprediritto\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/\"},\"author\":{\"name\":\"semprediritto\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#\\\/schema\\\/person\\\/2691163984d9670e417622b00a4c0f26\"},\"headline\":\"Novo Nordisk kauft deutsche Biotechfirma\",\"datePublished\":\"2024-03-27T14:56:55+00:00\",\"dateModified\":\"2025-08-27T09:28:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/\"},\"wordCount\":203,\"publisher\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Novo-Nordisk-scaled-1.jpg\",\"articleSection\":[\"Supply Chain News\"],\"inLanguage\":\"en-GB\",\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/en\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/\",\"url\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/\",\"name\":\"Novo Nordisk kauft deutsche Biotechfirma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Novo-Nordisk-scaled-1.jpg\",\"datePublished\":\"2024-03-27T14:56:55+00:00\",\"dateModified\":\"2025-08-27T09:28:44+00:00\",\"description\":\"Novo Nordisk \u00fcbernimmt das in Hannover ans\u00e4ssige Biotechnologieunternehmen Cardior Pharmaceuticals. Damit st\u00e4rkt Novo Nordisk nach eigener\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/#primaryimage\",\"url\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Novo-Nordisk-scaled-1.jpg\",\"contentUrl\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Novo-Nordisk-scaled-1.jpg\",\"width\":2560,\"height\":2560,\"caption\":\"Flaggen von Novo Nordisk, die im Wind wehen.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/kloepfel-consulting.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Supply Chain News\",\"item\":\"https:\\\/\\\/kloepfel-consulting.com\\\/category\\\/supply-chain-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Novo Nordisk kauft deutsche Biotechfirma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#website\",\"url\":\"https:\\\/\\\/kloepfel-consulting.com\\\/\",\"name\":\"KLOEPFEL by EPSA\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#organization\"},\"alternateName\":\"KLOEPFELbyEPSA\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kloepfel-consulting.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#organization\",\"name\":\"KLOEPFEL by EPSA\",\"alternateName\":\"KLOEPFELbyEPSA\",\"url\":\"https:\\\/\\\/kloepfel-consulting.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/logo.webp\",\"contentUrl\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/logo.webp\",\"width\":616,\"height\":284,\"caption\":\"KLOEPFEL by EPSA\"},\"image\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/KloepfelGroup\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/kloepfel-consulting-gmbh\",\"https:\\\/\\\/www.instagram.com\\\/kloepfel_by_epsa\\\/\"],\"description\":\"Einkaufsberatung f\u00fcr Einkauf, Logistik und Supply Chain\",\"email\":\"info@kloepfel-consulting.com\",\"telephone\":\"+4921194198433\",\"legalName\":\"Kloepfel Consulting GmbH\",\"foundingDate\":\"2007-02-01\",\"vatID\":\"DE254132249\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"51\",\"maxValue\":\"200\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#\\\/schema\\\/person\\\/2691163984d9670e417622b00a4c0f26\",\"name\":\"semprediritto\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g\",\"caption\":\"semprediritto\"},\"sameAs\":[\"https:\\\/\\\/kloepfel.sempre-diritto.de\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Novo Nordisk acquires German biotech company","description":"Novo Nordisk acquires the Hanover-based biotechnology company Cardior Pharmaceuticals. According to Novo Nordisk, this strengthens","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kloepfel-consulting.com\/en\/supply-chain-news\/novo-nordisk-buys-german-biotech-firm-11358\/","og_locale":"en_GB","og_type":"article","og_title":"Novo Nordisk kauft deutsche Biotechfirma","og_description":"Novo Nordisk \u00fcbernimmt das in Hannover ans\u00e4ssige Biotechnologieunternehmen Cardior Pharmaceuticals. Damit st\u00e4rkt Novo Nordisk nach eigener Aussage seine Produktpipeline im Bereich der Herz-Kreislauf-Erkrankungen.","og_url":"https:\/\/kloepfel-consulting.com\/en\/supply-chain-news\/novo-nordisk-buys-german-biotech-firm-11358\/","og_site_name":"KLOEPFEL by EPSA","article_publisher":"https:\/\/www.facebook.com\/KloepfelGroup","article_published_time":"2024-03-27T14:56:55+00:00","article_modified_time":"2025-08-27T09:28:44+00:00","og_image":[{"width":2200,"height":1608,"url":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/07\/kloepfelgroup.webp","type":"image\/webp"}],"author":"semprediritto","twitter_card":"summary_large_image","twitter_title":"Novo Nordisk kauft Cardior Pharmaceuticals f\u00fcr 1 Milliarde Euro","twitter_description":"Informieren Sie sich \u00fcber die \u00dcbernahme von Cardior durch Novo Nordisk.","twitter_misc":{"Written by":"semprediritto","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/#article","isPartOf":{"@id":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/"},"author":{"name":"semprediritto","@id":"https:\/\/kloepfel-consulting.com\/#\/schema\/person\/2691163984d9670e417622b00a4c0f26"},"headline":"Novo Nordisk kauft deutsche Biotechfirma","datePublished":"2024-03-27T14:56:55+00:00","dateModified":"2025-08-27T09:28:44+00:00","mainEntityOfPage":{"@id":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/"},"wordCount":203,"publisher":{"@id":"https:\/\/kloepfel-consulting.com\/#organization"},"image":{"@id":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/#primaryimage"},"thumbnailUrl":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/08\/Novo-Nordisk-scaled-1.jpg","articleSection":["Supply Chain News"],"inLanguage":"en-GB","copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/kloepfel-consulting.com\/en\/#organization"}},{"@type":"WebPage","@id":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/","url":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/","name":"Novo Nordisk acquires German biotech company","isPartOf":{"@id":"https:\/\/kloepfel-consulting.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/#primaryimage"},"image":{"@id":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/#primaryimage"},"thumbnailUrl":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/08\/Novo-Nordisk-scaled-1.jpg","datePublished":"2024-03-27T14:56:55+00:00","dateModified":"2025-08-27T09:28:44+00:00","description":"Novo Nordisk acquires the Hanover-based biotechnology company Cardior Pharmaceuticals. According to Novo Nordisk, this strengthens","breadcrumb":{"@id":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/#primaryimage","url":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/08\/Novo-Nordisk-scaled-1.jpg","contentUrl":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/08\/Novo-Nordisk-scaled-1.jpg","width":2560,"height":2560,"caption":"Flaggen von Novo Nordisk, die im Wind wehen."},{"@type":"BreadcrumbList","@id":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/kloepfel-consulting.com\/"},{"@type":"ListItem","position":2,"name":"Supply Chain News","item":"https:\/\/kloepfel-consulting.com\/category\/supply-chain-news\/"},{"@type":"ListItem","position":3,"name":"Novo Nordisk kauft deutsche Biotechfirma"}]},{"@type":"WebSite","@id":"https:\/\/kloepfel-consulting.com\/#website","url":"https:\/\/kloepfel-consulting.com\/","name":"KLOEPFEL by EPSA","description":"","publisher":{"@id":"https:\/\/kloepfel-consulting.com\/#organization"},"alternateName":"KLOEPFELbyEPSA","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kloepfel-consulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/kloepfel-consulting.com\/#organization","name":"KLOEPFEL by EPSA","alternateName":"KLOEPFELbyEPSA","url":"https:\/\/kloepfel-consulting.com\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/kloepfel-consulting.com\/#\/schema\/logo\/image\/","url":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/04\/logo.webp","contentUrl":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/04\/logo.webp","width":616,"height":284,"caption":"KLOEPFEL by EPSA"},"image":{"@id":"https:\/\/kloepfel-consulting.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/KloepfelGroup","https:\/\/www.linkedin.com\/company\/kloepfel-consulting-gmbh","https:\/\/www.instagram.com\/kloepfel_by_epsa\/"],"description":"Purchasing Advice for Procurement, Logistics, and Supply Chain","email":"info@kloepfel-consulting.com","telephone":"+4921194198433","legalName":"Kloepfel Consulting GmbH","foundingDate":"2007-02-01","vatID":"DE254132249","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"51","maxValue":"200"}},{"@type":"Person","@id":"https:\/\/kloepfel-consulting.com\/#\/schema\/person\/2691163984d9670e417622b00a4c0f26","name":"Always right","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g","caption":"semprediritto"},"sameAs":["https:\/\/kloepfel.sempre-diritto.de"]}]}},"_links":{"self":[{"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/posts\/11358","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/comments?post=11358"}],"version-history":[{"count":2,"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/posts\/11358\/revisions"}],"predecessor-version":[{"id":14750,"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/posts\/11358\/revisions\/14750"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/media\/11359"}],"wp:attachment":[{"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/media?parent=11358"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/categories?post=11358"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/tags?post=11358"},{"taxonomy":"referenzkategorie","embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/referenzkategorie?post=11358"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}